Ruth Gross

Opinion author

Ruth Gross is the vice-president of business development at Evogene, a veteran AI-computational chemistry and biology company, Gross leverages her 10+ years of expertise in medical, marketing, strategic partnerships and pipeline development to drive growth in biotech and life sciences. She is a doctor of veterinary medicine.

Beautifull Nellore beef cattle grazing intensive tropical pasture in Brazil project

Opinion

AI Enables Companies to Break From the Herd in Drug Development

Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI could change that.

April 7, 2025

6 min read

Ruth Gross